News & Views
Bill Burns Appointed as Non Executive Director
May 07 2010
Shire plc (Dublin) a specialty biopharmaceutical company has appointed Bill Burns to its Board as a Non Executive Director with immediate effect. Mr Burns has also been appointed a member of Shire’s Remuneration Committee. Mr Burns has a long and distinguished career in the global pharmaceuticals industry, most recently as CEO of Roche’s Pharmaceuticals Division and as a member of the Roche Group Corporate Executive Committee. He was involved in the acquisition and privatisation of Genentech, led the integration of Boehringer Mannheim Therapeutics and played a lead role in the negotiations resulting in Roche becoming a majority owner of Chugai in Japan. Following retirement in January this year, he has since been appointed to the Board of Directors of Roche Holdings Ltd and is a Board member of bothChugai Pharmaceuticals and of Genentech Inc.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 22 2024 Marrakech, Morroco
Making Pharmaceuticals Exhibition & Conference
Apr 23 2024 Coventry, UK
Apr 23 2024 Kintex, South Korea
Apr 23 2024 Seoul, South Korea
Apr 24 2024 Jakarta, Indonesia